地拉罗司应怎样购买呢?
Iron overload is very harmful, increasing the risk of infection, causing damage to multiple organ systems such as the heart, liver, endocrine system, and hematopoietic system, and accelerating the transformation of MDS into leukemia. Therefore, iron-removing therapy is particularly important for transfusion-dependent patients with a long expected survival time. The current mainstream iron-removing treatment drugs are.
A prospective, observational study in my country using liver, pancreas, and heart as monitoring indicators confirmed that deferasirox can improve organ function in patients with iron overload. The TELESTO study results released at ASH2018 also proved that deferasirox continuously reduces serum ferritin levels, while reducing the risk of heart function damage, liver function damage, transformation to leukemia and other events by 36.4%. In summary, deferasirox is easy to administer, can significantly reduce ferritin levels, and has a definite effect in protecting important target organ systems such as the liver, heart, and endocrine system. It is currently the preferred option for iron removal treatment.
Deferasirox is a ligand with three protrusions. Although the affinity of deferasirox dispersible tablets to zinc and copper is very low, the concentrations of these trace metals in the serum still decreased to varying degrees after administration. The tolerability and safety of deferasirox are relatively good among similar drugs.
Deferasirox may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dose or stop the medication. If the condition is severe or persistent, the medication should be stopped. 2. The patient’s vision or hearing may be affected. 3. It should be taken 30 minutes before meals. Deferasirox should be avoided combined with strong inducers of UDP-glucuronosyltransferase (UGT) (such as rifampicin, phenytoin, sedatives and hypnotics, protease inhibitors), cholestyramine, and should not be administered simultaneously with aluminum-containing antacids.
If Chinese patients want to buy Indian deferasirox, they can find regular overseas medical institutions in China to consult deferasirox. The staff of the Medical Companion Brigade will solve the patients' related problems.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)